Klaus Bendtzen

Cytotoxicity of Human <i>p</i> I 7 Interleukin-1 for Pancreatic Islets of Langerhans

Klaus Bendtzen, Thomas Mandrup‐Poulsen, Jørn Nerup et al. · Science · 1986 · 531 citations

Life Sciences, Endocrinology, Immunology +14

Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

Pål Aukrust, Thor Ueland, Egil Lien et al. · The American Journal of Cardiology · 1999 · 457 citations

Medicine, Cardiology, Immunology +13

Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial

Casper Steenholdt, Jørn Brynskov, Ole Østergaard Thomsen et al. · Gut · 2013 · 454 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

Per Soelberg Sørensen, Katja Maria Clemmesen, Klaus Bendtzen et al. · The Lancet · 2003 · 386 citations

Life Sciences, Immunology, Neurology +14

Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor α inhibitor infliximab

Klaus Bendtzen, Pierre Geborek, Morten Svenson et al. · Arthritis & Rheumatism · 2006 · 379 citations

Medicine, Immunology, Pharmacology +17